Literature DB >> 22342849

Effect of marathon run and air travel on pre- and post-run soluble d-dimer, microparticle procoagulant activity, and p-selectin levels.

Beth A Parker1, Amanda L Augeri, Jeffrey A Capizzi, Kevin D Ballard, Brian R Kupchak, Jeffrey S Volek, Christopher Troyanos, Peter Kriz, Pierre D'Hemecourt, Paul D Thompson.   

Abstract

D-dimer, microparticles, and p-selectin are venous thrombotic risk markers. Elevated p-selectin is associated with increased cardiovascular events. We examined the effects of exercise and air travel on the markers of vascular risk in marathon runners. Forty-one persons participating in the 114th Boston Marathon (April 19, 2010) were divided into travel (n = 23) and nontravel "control" (n = 18) groups according to whether they lived more than a 4-hour plane flight or less than a 2-hour car trip from Boston. The subjects provided venous blood samples the day before, immediately after, and after returning home the day after the marathon. The blood was analyzed for soluble d-dimer, microparticle procoagulant activity, and p-selectin. D-dimer levels increased more before to immediately after (142 ± 83 to 387 ± 196 ng/mL) in the travel group than in the controls (85 ± 26 to 233 ± 95 ng/mL; p = 0.02). Moreover, 6 travel subjects versus 0 controls had d-dimer values >500 ng/mL after returning home the day after the marathon, the clinical threshold for excluding venous thrombosis (p = 0.03). P-selectin increased with exercise (p <0.01) regardless of travel (p = 0.09) but age was related to p-selectin (p = 0.01) such that older subjects exhibited greater p-selectin values before (r(2) = 0.14; p = 0.02) and after returning home the day after the marathon (r(2) = 0.16, p = 0.01). In conclusion, the combination of exercise and travel increases venous and arterial thrombotic risk. Moreover, the p-selectin levels at rest and after exercise were greater with age. These results might explain the reports of venous thrombosis with air travel after athletic events and the reports of cardiac events in older participants running marathons.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342849     DOI: 10.1016/j.amjcard.2012.01.369

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Effect of cycling in the heat for 164 km on procoagulant and fibrinolytic parameters.

Authors:  Brian R Kupchak; Amy L McKenzie; Hui-Ying Luk; Cathy Saenz; Laura J Kunces; Lindsay A Ellis; Jakob L Vingren; Elaine C Lee; Kevin D Ballard; Evan C Johnson; Stavros A Kavouras; Matthew S Ganio; Jonathon E Wingo; Keith H Williamson; Lawrence E Armstrong
Journal:  Eur J Appl Physiol       Date:  2015-01-22       Impact factor: 3.078

Review 2.  Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future.

Authors:  Farah Omran; Ioannis Kyrou; Faizel Osman; Ven Gee Lim; Harpal Singh Randeva; Kamaljit Chatha
Journal:  Int J Mol Sci       Date:  2022-05-19       Impact factor: 6.208

3.  Compression socks and the effects on coagulation and fibrinolytic activation during marathon running.

Authors:  E K Zadow; M J Adams; S S X Wu; C M Kitic; I Singh; A Kundur; N Bost; A N B Johnston; J Crilly; A C Bulmer; S L Halson; J W Fell
Journal:  Eur J Appl Physiol       Date:  2018-07-24       Impact factor: 3.078

4.  Statins Attenuate the Increase in P-Selectin Produced by Prolonged Exercise.

Authors:  Amanda Zaleski; Jeffrey Capizzi; Kevin D Ballard; Christopher Troyanos; Aaron Baggish; Pierre D'Hemecourt; Paul D Thompson; Beth Parker
Journal:  J Sports Med (Hindawi Publ Corp)       Date:  2013-05-07

Review 5.  Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes.

Authors:  Emma Kate Zadow; Daniel William Taylor Wundersitz; Diane Louise Hughes; Murray John Adams; Michael Ian Charles Kingsley; Hilary Anne Blacklock; Sam Shi Xuan Wu; Amanda Clare Benson; Frédéric Dutheil; Brett Ashley Gordon
Journal:  Semin Thromb Hemost       Date:  2020-09-03       Impact factor: 4.180

6.  Report of a recurrent cerebral venous thrombosis in a young athlete.

Authors:  Sébastien Richard; Jean-Christophe Lacour; Birgit Frotscher; Ana Enea; Gioia Mione; Xavier Ducrocq
Journal:  BMC Neurol       Date:  2014-09-22       Impact factor: 2.474

7.  Additive effect of erythropoietin use on exercise-induced endothelial activation and hypercoagulability in athletes.

Authors:  Jules A A C Heuberger; Jelle J Posthuma; Dimitrios Ziagkos; Joris I Rotmans; Johannes M A Daniels; Pim Gal; Frederik E Stuurman; Henri M H Spronk; Hugo Ten Cate; Jacobus Burggraaf; Matthijs Moerland; Adam F Cohen
Journal:  Eur J Appl Physiol       Date:  2020-06-14       Impact factor: 3.078

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.